Lung screening

The National Lung Cancer Screening Program (NLCSP), in place from 1 July 2025, uses low dose computed tomography (CT) scans to look for lung cancer in high-risk people without any symptoms.

Lung screening

The National Lung Cancer Screening Program (NLCSP), in place from 1 July 2025, uses low dose computed tomography (CT) scans to look for lung cancer in high-risk people without any symptoms.

Treatment pathways and better health outcomes

Lung cancer is the fourth most common cancer diagnosed in Australia* but all too often is picked up at a late stage when the outcomes can be poor compared to other types of cancer. There is strong evidence that the treatment options are more effective when lung cancer is found earlier using low dose CT.  

The first of July 2025 sees the introduction of the NLCSP which aims to achieve better health outcomes for Australians by detecting lung cancer early.  

The Australian government program aims to pick up cases of lung cancer at an earlier stage providing a pathway to more effective treatment options. Our specialist radiologists, with background knowledge of the development of the program, are expert in the systems, AI and reporting the program requires to successfully screen for lung cancer in asymptomatic Australians.

*Australian Government | Australian Institute of Heath and Welfare | Cancer in Australia 2021

Who is eligible for the screening program?

Patients who meet the following criteria require a dedicated referral to I-MED for a low dose CT scan. To be eligible for the screening program, patients need to:

  • be aged between 50 and 70 years
  • show no signs or symptoms of lung cancer
  • have a history of at least 30 pack-years of cigarette smoking
  • be still smoking or have quit in the past 10 years. 

Screening services will begin for eligible people in July. I-MED Radiology, as Australia's largest provider of imaging services, is offering low dose CT screening across our CT-enabled nationwide. 

Why choose I-MED for the National Lung Cancer Screening Program

  • consistent reporting by an expert team of dedicated chest imaging specialists providing you with the clinical information you require to further support your patients
  • a single point of contact for reporting and follow up to facilitate ongoing care for your patients
  • a 3-day turnaround for reporting allowing you to promptly manage your patients
  • the lowest possible dosage, enabled by DOSE software, ensuring patient safety without compromising image quality
  • the consolidated benefits of our established connections with public and private healthcare networks  
  • access for patients across Australia through the largest network available supporting timely patient care when requested by referring practitioners.  

Why patients prefer I-MED 

  • conveniently located low dose screening clinics reducing travel time and unnecessary delays linked with distance  
  • remote area access available through mobile services to reach isolated communities  
  • access to our streamlined online booking system, available 24/7 via mobile or desktop, so patients can find the best time and location for their low-dose screening as quickly as possible  
  • we recognise and understand the vulnerability and stigma associated with patients living with any long-term addiction and treat your patients with respect and empathy  
  • a fully bulk billed service for the NLCSP, which patients can book online and access through the largest network of radiology clinics nationwide.

I-MED Radiology Webinar | 13 May 2025, 6:30pm

Register here

Banner for a webinar on the National Lung Cancer Screening Program featuring a stylised internal image of a human torso with lungs and trachea highlighted